お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
927295

世界の神経デバイス市場:製品、エンドユーザー別 - 市場機会分析および産業予測(2019年~2026年)

Neurology Devices Market by Product and End User : Global Opportunity Analysis and Industry Forecast, 2019-2026

出版日: | 発行: Allied Market Research | ページ情報: 英文 182 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
世界の神経デバイス市場:製品、エンドユーザー別 - 市場機会分析および産業予測(2019年~2026年)
出版日: 2020年01月01日
発行: Allied Market Research
ページ情報: 英文 182 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の神経デバイス市場は、2018年に92億4,267万ドルとなりました。同市場は、2019年から2026年にかけて8.1%のCAGRで成長する見通しで、2026年には174億1,040万ドルに達すると予測されています。同市場の成長は、 世界の老年人口の大幅な増加、低侵襲手術の需要増加、および先進神経デバイスの開発によって推進されています。また、世界の神経疾患の有病率の増加は、神経デバイスの需要を促進し、それによって世界の市場の成長を後押ししています。さらに、新製品の導入と神経デバイスの技術的進歩は、多くの神経血管障害の効率的な治療を支援し、予測期間中に市場拡大の機会を提供することが期待されています。ただし、これらのデバイスの承認に対する厳しい政府規制の施行と熟練した神経外科医の不足は、市場の成長を妨げるおそれのある重要な要因です。

当レポートは世界の神経デバイス市場について調査しており、市場機会、成長および阻害要因、製品・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • レポートの概要
  • ステークホルダーの主な利点
  • 調査手法
    • 二次調査
    • 一次調査
    • アナリストのツールとモデル

第2章 エグゼクティブサマリー

  • 主な調査結果
  • Cxoの見解

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資銘柄
  • ポーターのファイブフォース分析
  • 主要企業の位置づけ
  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会

第4章 市場分析:製品別

  • 概要
    • 市場規模と予測
  • 神経刺激装置
  • 脳神経外科用デバイス
  • インターベンショナル神経デバイス
  • 脳脊髄液管理デバイス
  • その他

第5章 市場分析:エンドユーザー別

  • 概要
    • 市場規模と予測
  • 病院
  • 外来手術センター
  • 神経内科

第6章 市場分析:地域別

  • 概要
    • 市場規模と予測
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ

第7章 企業プロファイル

  • Abbott Laboratories
  • B. Braun Melsungen Ag
  • Boston Scientific Corporation
  • Integra Lifesciences Holdings Corporation
  • Johnson & Johnson
  • Livanova Plc
  • Medtronic Plc
  • Magstim Co Ltd.
  • Penumbra, Inc.
  • Stryker Corporation
図表

List of Tables

  • Table 01. Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 02. Neurostimulation Devices Market, By Region, 2018-2026 ($Million)
  • Table 03. Neurosurgery Devices Market, By Region, 2018-2026 ($Million)
  • Table 04. Interventional Neurology Devices Market, By Region, 2018-2026 ($Million)
  • Table 05. Cerebrospinal Fluid Management Devices Market, By Region, 2018-2026 ($Million)
  • Table 06. Other Devices Market, By Region, 2018-2026 ($Million)
  • Table 07. Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 08. Neurology Devices Market For Hospitals, By Region, 2018-2026 ($Million)
  • Table 09. Neurology Devices Market For Ambulatory Surgery Centers, By Region, 2018-2026 ($Million)
  • Table 10. Neurology Devices Market For Neurology Clinics, By Region, 2018-2026 ($Million)
  • Table 11. Global Neurology Devices Market, By Region, 2018-2026 ($Million)
  • Table 12. North America Neurology Devices Market, By Country, 2018-2026 ($Million)
  • Table 13. North America Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 14. North America Neurology Devices Market, By End User, 2018-2026 ($Million),
  • Table 15. U.S. Neurology Devices Market By Product, 2018-2026 ($Million)
  • Table 16. U.S. Neurology Devices Market By End User, 2018-2026 ($Million)
  • Table 17. Canada Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 18. Canada Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 19. Mexico Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 20. Mexico Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 21. Europe Neurology Devices Market, By Country, 2018-2026 ($Million)
  • Table 22. Europe Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 23. Europe Neurology Devices Market, By End User, 2018-2026 ($Million),
  • Table 24. Germany Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 25. Germany Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 26. France Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 27. France Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 28. U.K. Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 29. U.K. Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 30. Italy Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 31. Italy Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 32. Rest of Europe Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 33. Rest of Europe Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 34. Asia-Pacific Neurology Devices Market, By Country, 2018-2026 ($Million)
  • Table 35. Asia-Pacific Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 36. Asia-Pacific Neurology Devices Market, By End User, 2018-2026 ($Million),
  • Table 37. Japan Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 38. Japan Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 39. China Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 40. China Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 41. India Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 42. India Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 43. Rest of Asia-Pacific Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 44. Rest of Asia-Pacific Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 45. Lamea Neurology Devices Market, By Country, 2018-2026 ($Million)
  • Table 46. Lamea Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 47. Lamea Neurology Devices Market, By End User, 2018-2026 ($Million),
  • Table 48. Brazil Neurology Devices Market, By Product 2018-2026 ($Million)
  • Table 49. Brazil Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 50. Saudi Arabia Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 51. Saudi Arabia Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 52. South Africa Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 53. South Africa Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 54. Rest of Lamea Neurology Devices Market, By Product, 2018-2026 ($Million)
  • Table 55. Rest of Lamea Neurology Devices Market, By End User, 2018-2026 ($Million)
  • Table 56. Abbott: Company Snapshot
  • Table 57. Abbott: Operating Segments
  • Table 58. Abbott: Product Portfolio
  • Table 59. B. Braun: Company Snapshot
  • Table 60. B. Braun: Operating Segments
  • Table 61. B. Braun: Product Portfolio
  • Table 62. Boston Scientific: Company Snapshot
  • Table 63. Boston Scientific: Operating Segments
  • Table 64. Boston Scientific: Product Portfolio
  • Table 65. Integra: Company Snapshot
  • Table 66. Integra: Operating Segments
  • Table 67. Integra: Product Portfolio
  • Table 68. Johnson & Johnson: Company Snapshot
  • Table 69. J&J: Operating Segment
  • Table 70. J&J.: Product Portfolio
  • Table 71. Livanova: Company Snapshot
  • Table 72. Livanova: Operating Segment
  • Table 73. Livanova: Product Portfolio
  • Table 74. Medtronic: Company Snapshot
  • Table 75. Medtronic: Operating Segments
  • Table 76. Medtronic: Product Portfolio
  • Table 77. Magstim: Operating Segment
  • Table 78. Magstim: Product Portfolio
  • Table 79. Penumbra.: Company Snapshot
  • Table 80. Penumbra.: Operating Segments
  • Table 81. Penumbra.: Product Portfolio
  • Table 82. Stryker: Company Snapshot
  • Table 83. Stryker: Operating Segments
  • Table 84. Stryker: Product Portfolio

List of Figures

  • Figure 01. Global Neurology Devices Market Segmentation
  • Figure 02. Top Investment Pockets
  • Figure 03. Top Player Positioning
  • Figure 04. Global Neurology Devices Market: Drivers, Restraint, And Opportunity
  • Figure 05. Comparative Share Analysis of Neurostimulation Devices Market, By Country, 2018 & 2026 (%)
  • Figure 06. Comparative Share Analysis of Neurosurgery Devices Market, By Country, 2018 & 2026 (%)
  • Figure 07. Comparative Share Analysis of Interventional Neurology Devices Market, By Country, 2018 & 2026 (%)
  • Figure 08. Comparative Share Analysis of Cerebrospinal Fluid Management Devices Market, By Country, 2018 & 2026 (%)
  • Figure 09. Comparative Share Analysis of Other Devices, By Country, 2018 & 2026 (%)
  • Figure 10. Comparative Share Analysis of Neurology Devices Market For Hospitals, By Country, 2018 & 2026 (%)
  • Figure 11. Comparative Share Analysis of Neurology Devices Market For Ambulatory Surgery Centers, By Country, 2018 & 2026 (%)
  • Figure 12. Comparative Share Analysis of Neurology Devices Market For Neurology Clinics, By Country, 2018 & 2026 (%)
  • Figure 13. Abbott: Net Sales, 2016-2018 ($Million)
  • Figure 14. Abbott: Revenue Share By Segment, 2018 (%)
  • Figure 15. Abbott: Revenue Share By Region, 2018 (%)
  • Figure 16. Net Sales, 2016-2018 ($Million)
  • Figure 17. B. Braun: Net Sales By Division, 2018 (%)
  • Figure 18. B. Braun: Net Sales By Region, 2018 (%)
  • Figure 19. Boston Scientific: Net Sales, 2016-2018 ($Million)
  • Figure 20. Boston Scientific: Revenue Share By Segment, 2018 (%)
  • Figure 21. Boston Scientific: Revenue Share By Geography, 2018 (%)
  • Figure 22. Integra: Revenue, 2016-2018 ($Million)
  • Figure 23. Integra: Revenue Share By Segment, 2018 (%)
  • Figure 24. Integra: Revenue Share By Region, 2018 (%)
  • Figure 25. J&J: Net Sales, 2016-2018 ($Million)
  • Figure 26. J&J: Revenue Share By Segmentation, 2016-2018(%)
  • Figure 27. J&J: Revenue Share By Region, 2016-2018(%)
  • Figure 28. Livanova: Revenue, 2016-2018 ($Million)
  • Figure 29. Livanova: Revenue Share By Segment, 2018 (%)
  • Figure 30. Livanova: Revenue Share By Region, 2018 (%)
  • Figure 31. Medtronic: Net Sales, 2016-2018 ($Million)
  • Figure 32. Medtronic: Revenue Share By Segment, 2018 (%)
  • Figure 33. Medtronic: Revenue Share By Region, 2018 (%)
  • Figure 34. Penumbra: Net Sales, 2016-2018($Million)
  • Figure 01. Penumbra: Revenue Share By Segment, 2018 (%)
  • Figure 02. Penumbra: Revenue Share By Region, 2018 (%)
  • Figure 03. Net Sales, 2016-2018 ($Million)
  • Figure 04. Stryker: Revenue Share By Segment, 2018 (%)
  • Figure 05. Stryker: Revenue Share By Region, 2018 (%)
目次
Product Code: LI_206321

The global neurological devices market was valued at $9,242.67 million in 2018, and is expected to reach $ 17,410.40 million by 2026, registering a CAGR of 8.1% from 2019 to 2026. Neurovascular devices such as cerebrospinal fluid management devices and interventional devices majorly find their application in the treatment of neurological disorders, including Alzheimer's, tumors, depression, and stroke. Moreover, there are various other devices or instruments used for the treatment of neurological diseases such as catheters, stents, ultrasonic aspirators, and stereotactic system.

The growth of the global neurology devices market is driven by significant rise in geriatric population across the globe, rise in demand for minimally invasive surgeries, and development of advanced neurological devices. In addition, increase in prevalence of neurological disorders across the globe propels the demand for neurology devices, thereby supplementing the growth of the global market. In addition, rise in geriatric population poses risk for increase in incidence of neurovascular disorders (such as stroke). However, enforcement of stringent government regulations toward the approval of these devices and lack of skilled neurosurgeons are the key factors anticipated to hamper the market growth. Conversely, the introduction of new products and technological advancements in neurological devices have aided in the efficient treatment of many neurovascular disorders, which is expected to provide lucrative opportunities for market expansion during the forecast period.

The global neurological devices market is segmented into product, end user, and region. By product, the market is categorized into neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices, and others. Depending on end user, it is classified into hospitals, neurology clinics, and ambulatory care centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of four regions is provided to determine the prevailing opportunities.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Product

  • Neurostimulation Devices
  • Neurosurgery Devices
  • Interventional Neurology Devices
  • Cerebrospinal Fluid Devices
  • Others

By End User

  • Hospitals
  • Neurology Clinics
  • Ambulatory Care Centers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Integra LifeSciences Holdings Corporation
  • LivaNova PLC
  • Johnson & Johnson
  • Medtronic Plc
  • Magstim Co Ltd.
  • Penumbra, Inc.
  • Stryker Corporation

Table of Contents

Chapter 1: Introduction

  • 1.1. Report Description
  • 1.2. Key Benefits For Stakeholders
  • 1.3. Research Methodology
    • 1.3.1. Secondary Research
    • 1.3.2. Primary Research
    • 1.3.3. Analyst Tools And Models

Chapter 2: Executive Summary

  • 2.1. Key Findings of The Study
  • 2.2. Cxo Perspective

Chapter 3: Market Overview

  • 3.1. Market Definition And Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
  • 3.3. Porter'S Five Forces Analysis
    • 3.3.1. Moderate Bargaining Power of Buyers
    • 3.3.2. Low Bargaining Power of Suppliers
    • 3.3.3. Moderate Threat of Substitutes
    • 3.3.4. Low Threat of New Entrants
    • 3.3.5. Moderate Competitive Rivalry
  • 3.4. Top Player Positioning
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
      • 3.5.1.1. Surge In Neurological Disorders
      • 3.5.1.2. Rising Demand For Noninvasive Diagnostic Techniques For Neurological Disorders
    • 3.5.2. Restraint
      • 3.5.2.1. Implementation of Stringent Government Regulations Towards Approval of Neurology Devices
    • 3.5.3. Opportunity
      • 3.5.3.1. Various Growth Opportunities In Emerging Economies

Chapter 4: Neurology Devices Market, By Product

  • 4.1. Overview
    • 4.1.1. Market Size And Forecast
  • 4.2. Neurostimulation Devices
    • 4.2.1. Key Market Trends And Opportunities
    • 4.2.2. Market Size And Forecast
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Neurosurgery Device
    • 4.3.1. Key Market Trends And Growth Opportunities
    • 4.3.2. Market Size And Forecast
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Interventional Neurology Devices
    • 4.4.1. Key Market Trends And Opportunities
    • 4.4.2. Market Size And Forecast
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Cerebrospinal Fluid Management Devices
    • 4.5.1. Key Market Trends And Opportunities
    • 4.5.2. Market Size And Forecast
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Others
    • 4.6.1. Key Market Trends And Opportunities
    • 4.6.2. Market Size And Forecast
    • 4.6.3. Market Share Analysis, By Country

Chapter 5: Neurology Devices Market, By End User

  • 5.1. Overview
    • 5.1.1. Market Size And Forecast
  • 5.2. Hospitals
    • 5.2.1. Market Size And Forecast
    • 5.2.2. Market Share Analysis, By Country
  • 5.3. Ambulatory Surgery Centers
    • 5.3.1. Market Size And Forecast
    • 5.3.2. Market Share Analysis, By Country
  • 5.4. Neurology Clinics
    • 5.4.1. Market Size And Forecast
    • 5.4.2. Market Share Analysis, By Country

Chapter 6: Neurology Devices Market, By Region

  • 6.1. Overview
    • 6.1.1. Market Size And Forecast
  • 6.2. North America
    • 6.2.1. Key Market Trends And Opportunities
    • 6.2.2. Market Size And Forecast, By Country
    • 6.2.3. Market Size And Forecast, By Product
    • 6.2.4. Market Size And Forecast, By End User
      • 6.2.4.1. U.S. Market Size And Forecast, By Product
      • 6.2.4.2. U.S. Market Size And Forecast, By End User
      • 6.2.4.3. Canada Market Size And Forecast, By Product
      • 6.2.4.4. Canada Market Size And Forecast, By End User
      • 6.2.4.5. Mexico Market Size And Forecast, By Product
      • 6.2.4.6. Mexico Market Size And Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Growth Factors And Opportunities
    • 6.3.2. Market Size And Forecast, By Country
    • 6.3.3. Market Size And Forecast, By Product
    • 6.3.4. Market Size And Forecast, By Product
      • 6.3.4.1. Germany Market Size And Forecast, By Product
      • 6.3.4.2. Germany Market Size And Forecast, By End User
      • 6.3.4.3. France Market Size And Forecast, By Product
      • 6.3.4.4. France Market Size And Forecast, By End User
      • 6.3.4.5. Uk Market Size And Forecast, By End User
      • 6.3.4.6. Uk Market Size And Forecast, By End User
      • 6.3.4.7. Italy Market Size And Forecast, By Product
      • 6.3.4.8. Italy Market Size And Forecast, By End User
      • 6.3.4.10. Rest of Europe Market Size And Forecast, By Product
      • 6.3.4.11. Rest of Europe Market Size And Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Growth Factors And Opportunities.
    • 6.4.2. Market Size And Forecast, By Country
    • 6.4.3. Market Size And Forecast, By Product
    • 6.4.4. Market Size And Forecast, By End User
      • 6.4.4.1. Japan Market Size And Forecast, By End User
      • 6.4.4.2. Japan Market Size And Forecast, By End User
      • 6.4.4.3. China Market Size And Forecast, By Product
      • 6.4.4.4. China Market Size And Forecast, By End User
      • 6.4.4.5. India Market Size And Forecast, By Product
      • 6.4.4.6. India Market Size And Forecast, By End User
      • 6.4.4.7. Rest of Asia-Pacific Market Size And Forecast, By Product
      • 6.4.4.8. Rest of Asia-Pacific Market Size And Forecast, By End User
  • 6.5. Lamea
    • 6.5.1. Key Growth Factors And Opportunities
    • 6.5.2. Market Size And Forecast, By Country
    • 6.5.3. Market Size And Forecast, By Product
    • 6.5.4. Market Size And Forecast, By End User
      • 6.5.4.1. Brazil Market Size And Forecast, By End User
      • 6.5.4.2. Brazil Market Size And Forecast, By End User
      • 6.5.4.3. Saudi Arabia Market Size And Forecast, By Product
      • 6.5.4.4. Saudi Arabia Market Size And Forecast, By End User
      • 6.5.5.1. South Africa Market Size And Forecast, By Product
      • 6.5.5.2. South Africa Market Size And Forecast, By End User
      • 6.5.5.3. Rest of Lamea Market Size And Forecast, By Product
      • 6.5.5.4. Rest of Lamea Market Size And Forecast, By End User

Chapter 7: Company Profiles

  • 7.1. Abbott Laboratories
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Operating Business Segments
    • 7.1.4. Product Portfolio
    • 7.1.5. Business Performance
  • 7.2. B. Braun Melsungen Ag
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Operating Business Segments
    • 7.2.4. Product Portfolio
    • 7.2.5. Business Performance
  • 7.3. Boston Scientific Corporation
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Operating Business Segments
    • 7.3.4. Product Portfolio
    • 7.3.5. Business Performance
    • 7.3.6. Key Strategic Moves And Developments
  • 7.4. Integra Lifesciences Holdings Corporation
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Operating Business Segments
    • 7.4.4. Product Portfolio
    • 7.4.5. Business Performance
    • 7.4.6. Key Strategic Moves And Developments
  • 7.5. Johnson & Johnson
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Operating Business Segments
    • 7.5.4. Product Portfolio
    • 7.5.5. Business Performance
  • 7.6. Livanova Plc
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Operating Business Segments
    • 7.6.4. Product Portfolio
    • 7.6.5. Business Performance
    • 7.6.6. Key Strategic Moves And Developments
  • 7.7. Medtronic Plc
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Operating Business Segments
    • 7.7.4. Product Portfolio
    • 7.7.5. Business Performance
    • 7.7.6. Key Strategic Moves And Developments
  • 7.8. Magstim Co Ltd.
    • 7.8.1. Company Overview
    • 7.8.2. Operating Business Segments
    • 7.8.3. Product Portfolio
    • 7.8.4. Key Strategic Moves And Developments
  • 7.9. Penumbra, Inc.
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Operating Business Segments
    • 7.9.4. Product Portfolio
    • 7.9.5. Business Performance
  • 7.10. Stryker Corporation
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Operating Business Segments
    • 7.10.4. Product Portfolio
    • 7.10.5. Business Performance
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.